BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA • FO0000000179

457 NOK
-9 (-1.93%)
Last: Feb 25, 2026, 04:19 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall BAKKA gets a fundamental rating of 4 out of 10. We evaluated BAKKA against 59 industry peers in the Food Products industry. BAKKA has only an average score on both its financial health and profitability. BAKKA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year BAKKA was profitable.
  • In the past year BAKKA had a positive cash flow from operations.
  • In the past 5 years BAKKA has always been profitable.
  • In the past 5 years BAKKA always reported a positive cash flow from operatings.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B -3B

1.2 Ratios

  • BAKKA has a Return On Assets of 2.75%. This is comparable to the rest of the industry: BAKKA outperforms 50.85% of its industry peers.
  • BAKKA has a Return On Equity (4.71%) which is comparable to the rest of the industry.
  • BAKKA has a worse Return On Invested Capital (3.12%) than 67.80% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BAKKA is in line with the industry average of 6.61%.
Industry RankSector Rank
ROA 2.75%
ROE 4.71%
ROIC 3.12%
ROA(3y)3.93%
ROA(5y)5.27%
ROE(3y)6.45%
ROE(5y)8.52%
ROIC(3y)5.25%
ROIC(5y)5.4%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • BAKKA has a Profit Margin of 7.42%. This is in the better half of the industry: BAKKA outperforms 79.66% of its industry peers.
  • In the last couple of years the Profit Margin of BAKKA has declined.
  • Looking at the Operating Margin, with a value of 10.19%, BAKKA is in the better half of the industry, outperforming 72.88% of the companies in the same industry.
  • BAKKA's Operating Margin has declined in the last couple of years.
  • The Gross Margin of BAKKA (67.75%) is better than 94.92% of its industry peers.
  • In the last couple of years the Gross Margin of BAKKA has grown nicely.
Industry RankSector Rank
OM 10.19%
PM (TTM) 7.42%
GM 67.75%
OM growth 3Y-21.27%
OM growth 5Y-3.56%
PM growth 3Y-26.85%
PM growth 5Y-5.79%
GM growth 3Y-1.41%
GM growth 5Y3.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAKKA is destroying value.
  • BAKKA has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BAKKA has been increased compared to 5 years ago.
  • Compared to 1 year ago, BAKKA has a worse debt to assets ratio.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • A Debt/Equity ratio of 0.45 indicates that BAKKA is not too dependend on debt financing.
  • BAKKA has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.39
WACC8.02%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • BAKKA has a Current Ratio of 6.55. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 6.55, BAKKA belongs to the top of the industry, outperforming 96.61% of the companies in the same industry.
  • BAKKA has a Quick Ratio of 1.56. This is a normal value and indicates that BAKKA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BAKKA (1.56) is better than 83.05% of its industry peers.
Industry RankSector Rank
Current Ratio 6.55
Quick Ratio 1.56
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.61% over the past year.
  • BAKKA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.36% yearly.
  • BAKKA shows a decrease in Revenue. In the last year, the revenue decreased by -4.45%.
  • BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%6.89%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%25.66%

3.2 Future

  • Based on estimates for the next years, BAKKA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.05% on average per year.
  • The Revenue is expected to grow by 8.13% on average over the next years. This is quite good.
EPS Next Y-48.66%
EPS Next 2Y7.66%
EPS Next 3Y14.05%
EPS Next 5YN/A
Revenue Next Year-7.25%
Revenue Next 2Y3.51%
Revenue Next 3Y7.23%
Revenue Next 5Y8.13%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.44, the valuation of BAKKA can be described as correct.
  • The rest of the industry has a similar Price/Earnings ratio as BAKKA.
  • BAKKA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.98.
  • With a Price/Forward Earnings ratio of 14.18, BAKKA is valued correctly.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BAKKA.
  • BAKKA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.44
Fwd PE 14.18
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BAKKA is valued a bit more expensive than 64.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.42
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • BAKKA's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.66%
EPS Next 3Y14.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • BAKKA has a Yearly Dividend Yield of 2.92%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.53, BAKKA pays a bit more dividend than its industry peers.
  • BAKKA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 96.22% of the earnings are spent on dividend by BAKKA. This is not a sustainable payout ratio.
DP96.22%
EPS Next 2Y7.66%
EPS Next 3Y14.05%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BAKKAFROST P/F

OSL:BAKKA (2/25/2026, 4:19:58 PM)

457

-9 (-1.93%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-09
Earnings (Next)05-19
Inst Owners58.12%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap27.14B
Revenue(TTM)7.01B
Net Income(TTM)520.17M
Analysts74.74
Price Target526.43 (15.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly Dividend12.7
Dividend Growth(5Y)N/A
DP96.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.59%
Min Revenue beat(2)-17.55%
Max Revenue beat(2)-11.63%
Revenue beat(4)0
Avg Revenue beat(4)-15.9%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-11.63%
Revenue beat(8)1
Avg Revenue beat(8)-12.62%
Revenue beat(12)2
Avg Revenue beat(12)-8.17%
Revenue beat(16)5
Avg Revenue beat(16)-6%
PT rev (1m)-3.62%
PT rev (3m)-4.51%
EPS NQ rev (1m)-18.61%
EPS NQ rev (3m)-13.57%
EPS NY rev (1m)0%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)-10.19%
Revenue NQ rev (3m)-9.53%
Revenue NY rev (1m)-4.1%
Revenue NY rev (3m)-4.63%
Valuation
Industry RankSector Rank
PE 16.44
Fwd PE 14.18
P/S 2.57
P/FCF N/A
P/OCF 16.7
P/B 1.63
P/tB 2.76
EV/EBITDA 15.42
EPS(TTM)27.8
EY6.08%
EPS(NY)32.22
Fwd EY7.05%
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)27.36
OCFY5.99%
SpS177.78
BVpS280.15
TBVpS165.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number418.61
Profitability
Industry RankSector Rank
ROA 2.75%
ROE 4.71%
ROCE 3.94%
ROIC 3.12%
ROICexc 3.17%
ROICexgc 4.24%
OM 10.19%
PM (TTM) 7.42%
GM 67.75%
FCFM N/A
ROA(3y)3.93%
ROA(5y)5.27%
ROE(3y)6.45%
ROE(5y)8.52%
ROIC(3y)5.25%
ROIC(5y)5.4%
ROICexc(3y)5.39%
ROICexc(5y)5.58%
ROICexgc(3y)7.37%
ROICexgc(5y)7.83%
ROCE(3y)6.65%
ROCE(5y)6.84%
ROICexgc growth 3Y-27.12%
ROICexgc growth 5Y-6.71%
ROICexc growth 3Y-25.68%
ROICexc growth 5Y-3.32%
OM growth 3Y-21.27%
OM growth 5Y-3.56%
PM growth 3Y-26.85%
PM growth 5Y-5.79%
GM growth 3Y-1.41%
GM growth 5Y3.18%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 3.33
Cap/Depr 144.57%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 71.96%
Profit Quality N/A
Current Ratio 6.55
Quick Ratio 1.56
Altman-Z N/A
F-Score3
WACC8.02%
ROIC/WACC0.39
Cap/Depr(3y)152.36%
Cap/Depr(5y)179.46%
Cap/Sales(3y)15.02%
Cap/Sales(5y)16.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%6.89%
EPS Next Y-48.66%
EPS Next 2Y7.66%
EPS Next 3Y14.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%25.66%
Revenue Next Year-7.25%
Revenue Next 2Y3.51%
Revenue Next 3Y7.23%
Revenue Next 5Y8.13%
EBIT growth 1Y-46.25%
EBIT growth 3Y-21.72%
EBIT growth 5Y4.67%
EBIT Next Year234.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.2%
OCF growth 3Y-3.54%
OCF growth 5Y17.87%

BAKKAFROST P/F / BAKKA.OL FAQ

What is the fundamental rating for BAKKA stock?

ChartMill assigns a fundamental rating of 4 / 10 to BAKKA.OL.


Can you provide the valuation status for BAKKAFROST P/F?

ChartMill assigns a valuation rating of 2 / 10 to BAKKAFROST P/F (BAKKA.OL). This can be considered as Overvalued.


How profitable is BAKKAFROST P/F (BAKKA.OL) stock?

BAKKAFROST P/F (BAKKA.OL) has a profitability rating of 5 / 10.


What is the expected EPS growth for BAKKAFROST P/F (BAKKA.OL) stock?

The Earnings per Share (EPS) of BAKKAFROST P/F (BAKKA.OL) is expected to decline by -48.66% in the next year.


How sustainable is the dividend of BAKKAFROST P/F (BAKKA.OL) stock?

The dividend rating of BAKKAFROST P/F (BAKKA.OL) is 3 / 10 and the dividend payout ratio is 96.22%.